Viralytics upgraded to hold VRACY

Viralytics Ltd Sp Ad Upgraded to “Hold” by Zacks (VRACY)

June 30th, 2015 - 0 comments - Filed Under - by Thomas Dobrow
https://**promotion blocked**.com/assets/widget/stocktwits_share.png

Zacks upgraded shares of Viralytics Ltd Sp Ad (NASDAQ:VRACY) from a sell rating to a hold rating in a research note issued to investors on Monday,Marketbeat.com reports.
According to Zacks, “Viralytics Limited is a biotechnology company. The Company develops oncolytic virotherapy for the treatment of cancers. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. Viralytics Limited is headquartered in Sydney, Australia. “
Zacks has also taken action a number of other stocks recently. The firm upgraded shares of Philippine Long Distance Telephone from a sell rating to a hold rating. Also, Zacks upgraded shares of Paragon Offshore PLC from a sell rating to a hold rating. Finally, Zacks upgraded shares of Grupo Aeroportuario del Pacifico from a hold rating to a buy rating. Zacks now has a $78.00 price target on that stock.
Shares of Viralytics Ltd Sp Ad (NASDAQ:VRACY) remained flat at $1.52 during during mid-day trading trading on Monday. Viralytics Ltd Sp Ad has a 52-week low of $$0.01 and a 52-week high of $$2.25. The stock’s 50-day moving average is $0.95 and its 200-day moving average is $0.81. The company’s market cap is $93.20 million.